As of Monday, January 05, Zenas BioPharma, Inc.’s ZBIO share price has dipped by 55.44%, which has investors questioning if ...

Zenas BioPharma stock collapsed Monday despite technically succeeding in a Phase 3 study of its treatment for a rare autoimmune disorder.

As of Wednesday, January 07, Mereo BioPharma Group plc’s MREO share price has surged by 9.18%, which has investors ...

Immix Biopharma Inc (NASDAQ: IMMX) shares are trading lower Monday after the company filed a new shelf registration statement ...

ESTERO, FL / ACCESS Newswire / January 14, 2026 / Aspire Biopharma Holdings, Inc. (Nasdaq:ASBP) ("Aspire" or the ...

Investing.com -- Aspire Biopharma Holdings Inc (NASDAQ:ASBP) stock surged 60.6% in premarket trading Wednesday after the ...

Despite the magnitude of the decline, the structural setup suggests caution remains warranted. Zenas is still firmly within its Sankhya period and has not yet transitioned into the Buddhi phase. Until ...

The Inducement Grant has a ten-year term and an exercise price per share of $19.93, which is equal to the closing price of Zenas’ common stock on the Grant Date. The Inducement Grant will vest over a ...

According to RedHill, while over 2% of Americans take GLP-1 receptor agonists, estimates suggest up to 50% discontinue treatment within three months due to side effects. Goldman Sachs estimates this ...

British biopharma major GSK to acquire US-based biopharma company RAPT Therapeutics via a $2.2 billion deal. Here's what ...

TORONTO, Nov. 26, 2025 (GLOBE NEWSWIRE) -- Quantum BioPharma Ltd. (NASDAQ: QNTM) (CSE: QNTM) (FRA: 0K91) (“Quantum BioPharma ”), is pleased to announce that national television network CTV News’ ...

Detailed price information for Arbutus Biopharma Corp (ABUS-Q) from The Globe and Mail including charting and trades.